Epidemiología

  • Bibliografía epidemiología (actualizado 23 abril -



  1. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet. febrero de 2020;395(10223):514-23.

  2. Park M, Cook AR, Lim JT, Sun Y, Dickens BL. A Systematic Review of COVID-19 Epidemiology Based on Current Evidence. JCM. 31 de marzo de 2020;9(4):967.

  3. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 16 de abril de 2020;382(16):1564-7.

  4. Morawska L, Cao J. Airborne transmission of SARS-CoV-2: The world should face the reality. Environment International. junio de 2020;139:105730.

  5. Xu S, Li Y. Beware of the second wave of COVID-19. The Lancet. abril de 2020;S014067362030845X.

  6. Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. Journal of Infection. abril de 2020;S0163445320301705.

  7. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 28 de febrero de 2020;NEJMoa2002032.

  8. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. marzo de 2020;395(10229):1054-62.

  9. Spellberg B, Haddix M, Lee R, Butler-Wu S, Holtom P, Yee H, et al. Community Prevalence of SARS-CoV-2 Among Patients With Influenzalike Illnesses Presenting to a Los Angeles Medical Center in March 2020. JAMA [Internet]. 31 de marzo de 2020 [citado 23 de abril de 2020]; Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2764137

  10. Nicastri E, D’Abramo A, Faggioni G, De Santis R, Mariano A, Lepore L, et al. Coronavirus disease (COVID-19) in a paucisymptomatic patient: epidemiological and clinical challenge in settings with limited community transmission, Italy, February 2020. Eurosurveillance [Internet]. 19 de marzo de 2020 [citado 23 de abril de 2020];25(11). Disponible en: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.11.2000230

  11. Lipsitch M, Swerdlow DL, Finelli L. Defining the Epidemiology of Covid-19 — Studies Needed. N Engl J Med. 26 de marzo de 2020;382(13):1194-6.

  12. Majumder MS, Mandl KD. Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility. The Lancet Global Health. marzo de 2020;S2214109X20301133.

  13. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. N Engl J Med. 26 de marzo de 2020;382(13):1199-207.

  14. Centro de Coordinación de Alertas y Emergencias Sanitarias, Ministerio de Sanidad. Gobierno de España. Enfermedad por coronavirus, COVID-19 Actualización, 17 de abril 2020 [Internet]. 2020 [citado 23 de abril de 2020]. Disponible en: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/20200417_ITCoronavirus.pdf

  15. Xu B, Gutierrez B, Mekaru S, Sewalk K, Goodwin L, Loskill A, et al. Epidemiological data from the COVID-19 outbreak, real-time case information. Sci Data. diciembre de 2020;7(1):106.

  16. Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. The Lancet Infectious Diseases. marzo de 2020;S1473309920302437.

  17. Berhe B, Legese H, Degefa H, Adhanom G, Gebrewahd A, Mardu F, et al. Global epidemiology, pathogenesis, immune response, diagnosis, treatment, economic and psychological impact, challenges, and future prevention of COVID-19: A scoping review [Internet]. Public and Global Health; 2020 abr [citado 23 de abril de 2020]. Disponible en: http://medrxiv.org/lookup/doi/10.1101/2020.04.02.20051052

  18. Grupo de Análisis Científico de Coronavirus del ISCIII. Glosario de Terminos Epidemiologicos_ISCIII.pdf [Internet]. 2020 [citado 23 de abril de 2020]. Disponible en: https://www.conprueba.es/sites/default/files/noticias/2020-04/GLOSARIO%20DE%20T%C3%89RMINOS%20EPIDEMIOL%C3%93GICOS_1.pdf

  19. Grafico periodo de infectividad.jpeg.

  20. Orea L, Álvarez IC. How effective has been the Spanish lockdown to battle COVID-19_ A spatial analysis of the coronavirus propagation across provinces [Internet]. 2020 [citado 23 de abril de 2020]. Disponible en: http://documentos.fedea.net/pubs/dt/2020/dt2020-03.pdf

  21. Medeiros de Figueiredo A, Daponte Codina A, Moreira Marculino Figueiredo D, Saez M, Cabrera León A. Impact of lockdown on COVID-19 incidence and mortality in China: an interrupted time series study [submitted]. Bulletin World Health Organization. 4 de junio de 2020;

  22. de Figueiredo AM, Codina AD, de Figueiredo DCMM, Gil-García E, Kalache A. Letalidad del COVID-19: ausencia de patrón epidemiológico. Gaceta Sanitaria. abril de 2020;S0213911120300844.

  23. Krantz SG, Rao ASRS. Level of underreporting including underdiagnosis before the first peak of COVID-19 in various countries: Preliminary retrospective results based on wavelets and deterministic modeling. Infect Control Hosp Epidemiol. 9 de abril de 2020;1-3.

  24. Modelización Epidemiológica del COVID-19 para España 1 de abril de 2020. MPG Journal [Internet]. 3 de abril de 2020 [citado 23 de abril de 2020];3(Especial). Disponible en: http://mpgjournal.mpg.es/index.php/journal/article/view/425

  25. Borges do Nascimento IJ, Cacic N, Abdulazeem HM, von Groote TC, Jayarajah U, Weerasekara I, et al. Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis. JCM. 30 de marzo de 2020;9(4):941.

  26. Bianconi A, Marcelli A, Campi G, Perali A. Ostwald Growth Rate in Controlled Covid-19 Epidemic Spreading as in Arrested Growth in Quantum Complex Matter. Condensed Matter. 27 de marzo de 2020;5(2):23.

  27. Unidad de Asesoramiento Científico-técnico, Avalia-t, de la Agencia del Conocimiento en Salud (ACIS). Papel de las personas infectadas asintomaticas en la transmisión del coronavirus sars-cov-2 [Internet]. Santiago de Compostela: Xunta de Galicia; 2020 abril [citado 23 de abril de 2020] p. 16. Disponible en: https://coronavirus.sergas.gal/Contidos/Documents/290/CompilacResumos_Asintomaticos.pdf

  28. Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science. 14 de abril de 2020;eabb5793.

  29. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-WHO_OMS-19).pdf.

  30. Croda JHR, Garcia LP. Resposta imediata da Vigilância em Saúde à epidemia da COVID-19. Epidemiologia e Serviços de Saúde [Internet]. marzo de 2020 [citado 23 de abril de 2020];29(1). Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2237-96222020000100100&lng=pt&nrm=iso&tlng=pt

  31. Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. mayo de 2020;51(9):843-51.

  32. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med. 19 de marzo de 2020;382(12):1177-9.

  33. Porcheddu R, Serra C, Kelvin D, Kelvin N, Rubino S. Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. J Infect Dev Ctries. 29 de febrero de 2020;14(02):125-8.

  34. He X, Lau EHY, Wu P, Deng X, Wang J, Hao X, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med [Internet]. 15 de abril de 2020 [citado 23 de abril de 2020]; Disponible en: http://www.nature.com/articles/s41591-020-0869-5

  35. To KK-W, Tsang OT-Y, Leung W-S, Tam AR, Wu T-C, Lung DC, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. The Lancet Infectious Diseases. marzo de 2020;S1473309920301961.

  36. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 17 de febrero de 2020;41(2):145-51.

  37. Delanghe JR, Speeckaert MM, De Buyzere ML. The host’s angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections. Clinica Chimica Acta. junio de 2020;505:192-3.

  38. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med [Internet]. 10 de marzo de 2020 [citado 23 de abril de 2020]; Disponible en: https://annals.org/aim/fullarticle/2762808/incubation-period-coronavirus-disease-2019-covid-19-from-publicly-reported

  39. Bourouiba L. Turbulent Gas Clouds and Respiratory Pathogen Emissions: Potential Implications for Reducing Transmission of COVID-19. JAMA [Internet]. 26 de marzo de 2020 [citado 23 de abril de 2020]; Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2763852

  40. Diaz LF. Vigilancia de los excesos de mortalidad por todas las causas. MoMo. :18.

  41. Liu Y, Yan L-M, Wan L, Xiang T-X, Le A, Liu J-M, et al. Viral dynamics in mild and severe cases of COVID-19. The Lancet Infectious Diseases. marzo de 2020;S1473309920302322.

  42. Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature [Internet]. 1 de abril de 2020 [citado 23 de abril de 2020]; Disponible en: http://www.nature.com/articles/s41586-020-2196-x

  43. Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, et al. Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses. 27 de marzo de 2020;12(4):372.



Chou R, Dana T, Buckley DI, Selph S, Fu R, Totten AM. Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers: A Living Rapid Review. Ann Intern Med. 2020 May 5. [consultada el 11/05/2020] doi: 10.7326/M20-1632. Epub ahead of print. PMID: 32369541. Disponible en: https://annals.org/aim/fullarticle/2765801/epidemiology-risk-factors-coronavirus-infection-health-care-workers-living-rapid